Lung cancer genotype-based therapy and predictive biomarkers: present and future.

Abstract

CONTEXT The advent of genotype-based therapy and predictive biomarkers for lung cancer has thrust the pathologist into the front lines of precision medicine for this deadly disease. OBJECTIVE To provide the clinical background, current status, and future perspectives of molecular targeted therapy for lung cancer patients, including the pivotal… (More)
DOI: 10.5858/arpa.2012-0508-RA

Topics

Cite this paper

@article{Cagle2012LungCG, title={Lung cancer genotype-based therapy and predictive biomarkers: present and future.}, author={Philip T. Cagle and Timothy Craig Allen}, journal={Archives of pathology & laboratory medicine}, year={2012}, volume={136 12}, pages={1482-91} }